Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.8 CAD | 0.00% | -0.55% | -15.89% |
Sales 2024 * | 120M 87.62M 7.31B | Sales 2025 * | 128M 93.64M 7.81B | Capitalization | 82.76M 60.5M 5.05B |
---|---|---|---|---|---|
Net income 2024 * | -6M -4.39M -366M | Net income 2025 * | -13M -9.5M -793M | EV / Sales 2024 * | 0.69 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.65 x |
P/E ratio 2024 * |
-11.4
x | P/E ratio 2025 * |
-7.52
x | Employees | 103 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.59% |
Latest transcript on Theratechnologies Inc.
1 week | -0.55% | ||
Current month | -19.28% | ||
1 month | -6.25% | ||
3 months | -16.28% | ||
6 months | +41.73% | ||
Current year | -15.89% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Lévesque
CEO | Chief Executive Officer | 60 | 06/20/06 |
Philippe Dubuc
DFI | Director of Finance/CFO | 57 | 24/16/24 |
Chief Tech/Sci/R&D Officer | 61 | 01/07/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Molson
BRD | Director/Board Member | 56 | 16/20/16 |
Frank Holler
BRD | Director/Board Member | 67 | 23/21/23 |
Director/Board Member | 80 | 08/06/08 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 1.8 | 0.00% | 14,756 |
25/24/25 | 1.8 | -2.70% | 10,185 |
24/24/24 | 1.85 | -2.12% | 16,019 |
23/24/23 | 1.89 | +2.16% | 5,402 |
22/24/22 | 1.85 | +2.21% | 5,600 |
Delayed Quote Toronto S.E., April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.89% | 60.46M | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
-9.14% | 11.95B | |
+5.24% | 8.71B | |
-8.42% | 8.12B |
- Stock Market
- Equities
- TH Stock